Patents by Inventor Cynthia Bamdad

Cynthia Bamdad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized anti-MUC1* antibodies
    Patent number: 12006371
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: June 11, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Media for stem cell proliferation and induction
    Patent number: 11976295
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Grant
    Filed: January 12, 2023
    Date of Patent: May 7, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Diagnostic methods using anti-MUC1* antibodies
    Patent number: 11976132
    Abstract: The present application discloses a method of determining suitability of treating a patient suffering from cancer or metastasis of cancer characterized by aberrant expression of MUC1, with a MUC1* targeting therapeutic.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: May 7, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventor: Cynthia Bamdad
  • Method of screening for agents for differentiating stem cells
    Patent number: 11931347
    Abstract: The present application discloses a method for identifying an agent for the treatment or prevention of cancer or metastatic cancer comprising the steps of contacting stem cell with a potential agent, and identifying an agent that induces differentiation, or inhibits stem cell pluripotency or growth of the stem cell, wherein such agent is determined to be an anti-cancer agent.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: March 19, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Scott Moe
  • Humanized anti-MUC1* antibodies
    Patent number: 11897967
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: February 13, 2024
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • MUC1* ANTIBODIES
    Publication number: 20230295340
    Abstract: The present describes monoclonal antibodies.
    Type: Application
    Filed: December 6, 2022
    Publication date: September 21, 2023
    Inventors: Cynthia Bamdad, Sanjeev Mahanta
  • MEDIA FOR STEM CELL PROLIFERATION AND INDUCTION
    Publication number: 20230287338
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Application
    Filed: January 12, 2023
    Publication date: September 14, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • HUMANIZED ANTI-MUC1* ANTIBODIES
    Publication number: 20230279142
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Application
    Filed: August 4, 2022
    Publication date: September 7, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20230279141
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: June 8, 2021
    Publication date: September 7, 2023
    Inventors: Cynthia BAMDAD, Benoit SMAGGHE
  • Humanized anti-MUC1* antibodies
    Patent number: 11746159
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: September 5, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20230242678
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: June 27, 2021
    Publication date: August 3, 2023
    Inventors: Cynthia BAMDAD, Benoit SMAGGHE
  • METHODS FOR DERIVING DOPAMINERGIC NEURONS FROM PLURIPOTENT STEM CELLS
    Publication number: 20230242874
    Abstract: The present application discloses a method of producing dopaminergic neurons from human stem cells by adding or increasing concentration of vitamin into neuro basal media at approximately Day 20+/?3 of a protocol for differentiating pluripotent stem cells into dopaminergic neurons.
    Type: Application
    Filed: June 28, 2021
    Publication date: August 3, 2023
    Inventors: Cynthia BAMDAD, Kevin R. YI, Scott T. MOE, Thomas JEON
  • Method of treating an NME7 expressing cancer with a peptide
    Patent number: 11702483
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: July 18, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • HUMANIZED ANTI-MUC1* ANTIBODIES
    Publication number: 20230183373
    Abstract: The present application discloses humanized antibodies and antibody like proteins and fragments thereof.
    Type: Application
    Filed: August 4, 2022
    Publication date: June 15, 2023
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • Media for stem cell proliferation and induction
    Patent number: 11591565
    Abstract: The present application discloses a cell culture media for growth, maintenance and induction of reversion to a less mature state of a cell comprising a MUC1* activating ligand.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: February 28, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • NME VARIANT SPECIES EXPRESSION AND SUPPRESSION
    Publication number: 20230049461
    Abstract: The present application discloses a method for generating less mature cells from starting cells including inducing the starting cells to revert to a less mature state including increasing the amount of an NME family member whose multimerization state is the biologically active state or decreasing the relative amount of an NME family member whose multimerization state is the biologically inactive state.
    Type: Application
    Filed: September 27, 2022
    Publication date: February 16, 2023
    Inventor: Cynthia BAMDAD
  • MUC1* antibodies
    Patent number: 11560435
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: January 24, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Sanjeev Mahanta
  • ANTI-CANCER PEPTIDE
    Publication number: 20220289865
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: April 12, 2022
    Publication date: September 15, 2022
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER METASTASIS
    Publication number: 20220259324
    Abstract: The present application discloses anti-NME antibodies and their use in treating or preventing diseases.
    Type: Application
    Filed: August 3, 2021
    Publication date: August 18, 2022
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Benoit Smagghe
  • METHODS FOR CULTURING STEM AND PROGENITOR CELLS
    Publication number: 20220252604
    Abstract: The present application describes a method of culturing, expanding or growing stem or stem-like cells or induced pluripotent stem cells on a surface, including attaching the cells to the surface through a ligand that binds to the surface and the cells.
    Type: Application
    Filed: June 21, 2021
    Publication date: August 11, 2022
    Inventor: Cynthia Bamdad